SCHEMBL25826194

SCHEMBL25826194

O=[N+]([O-])c1ccc(Nc2ccncc2)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.48
POLB P06746 3/20 0.48
MAPK1 P28482 2/20 0.48
MITF O75030 1/20 0.48
ALDH1A1 P00352 4/20 0.47
HTT P42858 2/20 0.47
RAB9A P51151 1/20 0.47
RAD52 P43351 1/20 0.43
KMT2A Q03164 4/20 0.41
USP2 O75604 2/20 0.41
ALOX12 P18054 2/20 0.41
MEN1 O00255 2/20 0.41
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
KDM4E B2RXH2 1/20 0.38
THRB P10828 1/20 0.38
MCL1 Q07820 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
DHFR P00374 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20455528 0.85 L3MBTL1 (0.58) MAPTMAPK1ALDH1A1HTTKMT2A
SCHEMBL25822003 0.78 MAPT (0.46) MAPTPOLBMAPK1MITFALDH1A1
SCHEMBL3178389 0.77 MAPT (0.71) MAPTPOLBMAPK1MITFALDH1A1
SCHEMBL14919183 0.75 MAPT (0.47) MAPTPOLBALDH1A1RAB9AKMT2A
SCHEMBL31580426 0.75 ALDH1A1 (0.52) MAPTPOLBALDH1A1RAB9AKMT2A
SCHEMBL1097891 0.75 ALDH1A1 (0.52) MAPTPOLBALDH1A1RAB9AKMT2A
SCHEMBL4474721 0.74 KMT2A (0.58) MAPTPOLBMAPK1HTTKMT2A
SCHEMBL4730262 0.74 TSHR (0.47) MAPTALDH1A1HTTRAB9AKMT2A
Hydrochloric Acid SCHEMBL15528630 0.74 MAPT (0.46) MAPTPOLBALDH1A1RAB9AKMT2A
SCHEMBL17055036 0.71 MEN1 (0.45) MAPTPOLBALDH1A1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR MAPT 3999/4885POLB 2609/4885MAPK1 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.